iTRAQ-based quantitative proteomics analysis of the potential application of secretoneurin gene therapy for cardiac hypertrophy induced by DL-isoproterenol hydrochloride in mice

被引:0
作者
Chen, Huali [1 ]
Wu, Mingjun [2 ]
Jiang, Wei [3 ]
Liu, Xiang [2 ]
Zhang, Jun [2 ]
Yu, Chao [1 ]
机构
[1] Chongqing Med Univ, Coll Pharm, Mailbox 308,1 Yixueyuan Rd, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Inst Life Sci, Chongqing 400016, Peoples R China
[3] Sichuan Univ, West China Hosp, Mol Med Res Ctr, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
secretoneurin; cardiac hypertrophy; isobaric tags for relative and absolute quantification; proteomics; apolipoprotein C-III; APOLIPOPROTEIN-C-III; HEART-FAILURE; CHROMOGRANIN-A; MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; GROWTH; IDENTIFICATION; BIOMARKERS; PROTEINS; SERUM;
D O I
10.3892/ijmm.2020.4472
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A previous study by our group demonstrated a protective role of the neuropeptide secretoneurin (SN) in DL-isoproterenol hydrochloride (ISO)-induced cardiac hypertrophy in mice. To further characterize the molecular mechanism of SN treatment, an isobaric tags for relative and absolute quantification (iTRAQ)-based quantitative proteomic analysis was applied to identify putative target proteins and molecular pathways. An SN expression vector was injected into the myocardial tissues of mice, and the animals were then subcutaneously injected with ISO (5 mg/kg/day) for 7 days to induce cardiac hypertrophy. The results of echocardiography and hemodynamic measurements indicated that the function of the heart impaired by ISO treatment was significantly ameliorated via SN gene injection. The investigation of heart proteomics was performed by iTRAQ-based liquid chromatography-tandem mass spectrometry analysis. A total of 2,044 quantified proteins and 15 differentially expressed proteins were associated with SN overexpression in mice with cardiac hypertrophy. Functional enrichment analysis demonstrated that these effects were possibly associated with metabolic processes. A protein-protein interaction network analysis was constructed and the data indicated that apolipoprotein C-III (Apoc3) was associated with the positive effect of SN on the induction of cardiac hypertrophy in mice. The present study proposed a potential mechanism of SN action on Apoc3 upregulation that may contribute to the amelioration of cardiac hypertrophy. These findings can aid the clinical application of SN in patients with cardiac hypertrophy.
引用
收藏
页码:793 / 804
页数:12
相关论文
共 58 条
[1]   The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial Infarction by Stimulation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells [J].
Albrecht-Schgoer, Karin ;
Schgoer, Wilfried ;
Holfeld, Johannes ;
Theurl, Markus ;
Wiedemann, Dominik ;
Steger, Christina ;
Gupta, Rajesh ;
Semsroth, Severin ;
Fischer-Colbrie, Reiner ;
Beer, Arno G. E. ;
Stanzl, Ursula ;
Huber, Eva ;
Misener, Sol ;
Dejaco, Daniel ;
Kishore, Raj ;
Pachinger, Otmar ;
Grimm, Michael ;
Bonaros, Nikolaos ;
Kirchmair, Rudolf .
CIRCULATION, 2012, 126 (21) :2491-+
[2]   Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality [J].
Ceconi, C ;
Ferrari, R ;
Bachetti, T ;
Opasich, C ;
Volterrani, M ;
Colombo, B ;
Parrinello, G ;
Corti, A .
EUROPEAN HEART JOURNAL, 2002, 23 (12) :967-974
[3]   Secretoneurin facilitates endothelium-dependent relaxations in porcine coronary arteries [J].
Chan, Calvin K. Y. ;
Vanhoutte, Paul M. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2011, 300 (04) :H1159-H1165
[4]   ITRAQ-based quantitative proteomic analysis of MG63 in response to HIF-1α inducers [J].
Chen, Chunxia ;
Hao, Xuehui ;
Geng, Zhirong ;
Wang, Zhilin .
JOURNAL OF PROTEOMICS, 2020, 211
[5]   Secretoneurin suppresses cardiac hypertrophy through suppression of oxidant stress [J].
Chen, Hua-Li ;
Liu, Yan ;
Jiang, Wei ;
Wang, Xiao-xiao ;
Yuan, Guo-lin ;
Zhao, Yi-lin ;
Yu, Chao .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 822 :13-24
[6]   Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy [J].
Chen, HuaLi ;
Wang, Xue ;
Tong, MingMing ;
Wu, Dan ;
Wu, Sisi ;
Chen, JiaXiang ;
Wang, XiaoXiao ;
Wang, XuLei ;
Kang, Yu ;
Tang, Hong ;
Tang, ChaoShu ;
Jiang, Wei .
PLOS ONE, 2013, 8 (05)
[7]   A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats [J].
Chowdhury, Debabrata ;
Tangutur, Anjana Devi ;
Khatua, Tarak Nath ;
Saxena, Priyanka ;
Banerjee, Sanjay K. ;
Bhadra, Manika Pal .
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
[8]   Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure [J].
Chugh, Shaan ;
Ouzounian, Maral ;
Lu, Zhen ;
Mohamed, Shanas ;
Li, Wenping ;
Bousette, Nicolas ;
Liu, Peter P. ;
Gramolini, Anthony O. .
PROTEOMICS, 2013, 13 (15) :2324-2334
[9]   Role of autocrine/paracrine mechanisms in response to myocardial strain [J].
Cingolani, Horacio E. ;
Ennis, Irene L. ;
Aiello, Ernesto A. ;
Perez, Nestor G. .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2011, 462 (01) :29-38
[10]   MODULATION OF LIPOPROTEIN B BINDING TO THE LDL RECEPTOR BY EXOGENOUS LIPIDS AND APOLIPOPROTEIN-CI, APOLIPOPROTEIN-CII, APOLIPOPROTEIN-CIII, AND APOLIPOPROTEIN-E [J].
CLAVEY, V ;
LESTAVELDELATTRE, S ;
COPIN, C ;
BARD, JM ;
FRUCHART, JC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (07) :963-971